RadNet, Inc.
RDNT
Rangering i aksjer
#3234
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Aksjekurs
$69.56
Sist synkronisert: 2026-10-19
Markedsverdi
$5.47B
Endring (1 dag)
1.10%
Endring (1 år)
-11.33%
Land
US
Handel RadNet, Inc. (RDNT)
Kategori
Healthcare
Antall utestående aksjer for RadNet, Inc. (RDNT)
Antall utestående aksjer per June 2026: 77.79M
Ifølge RadNet, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 77.79M. Ved slutten av December 2023 hadde selskapet 63.58M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for RadNet, Inc. (RDNT) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 77.79M | 6.51% |
| 2024 | 73.04M | 14.87% |
| 2023 | 63.58M | 12.94% |
| 2022 | 56.29M | 7.23% |
| 2021 | 52.50M | 3.15% |
| 2020 | 50.89M | 2.45% |
| 2019 | 49.67M | 3.24% |
| 2018 | 48.11M | 2.63% |
| 2017 | 46.88M | 1.38% |
| 2016 | 46.24M | 5.57% |
| 2015 | 43.81M | 6.66% |
| 2014 | 41.07M | 4.93% |
| 2013 | 39.14M | 3.68% |
| 2012 | 37.75M | 1.03% |
| 2011 | 37.37M | 1.40% |
| 2010 | 36.85M | 2.24% |
| 2009 | 36.05M | 0.91% |
| 2008 | 35.72M | 3.26% |
| 2007 | 34.59M | 64.62% |
| 2006 | 21.01M | 1.99% |
| 2005 | 20.60M | 0.70% |
| 2004 | 20.46M | 8.30% |
| 2003 | 18.89M | -7.57% |
| 2002 | 20.44M | 2.29% |
| 2001 | 19.98M | 2.48% |
| 2000 | 19.50M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 376.93% |
US
|
|
| 705.30M | 806.69% |
US
|
|
| 143.28M | 84.19% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 262.52% |
US
|
